Jaime Houghton

Monitoring a clinical trial conducted under the Food and Drug Administration regulations allowing a waiver of prospective informed consent: the diaspirin cross-linked hemoglobin traumatic hemorrhagic shock efficacy trial.

D. Berry, R. Bechhofer, R. Lewis, 2001, Annals of emergency medicine.

The informed consent process and the use of the exception to informed consent in the clinical trial of diaspirin cross-linked hemoglobin (DCLHb) in severe traumatic hemorrhagic shock. DCLHb Traumatic Hemorrhagic Shock study group.

D. Gens, G. Rodman, E. Sloan, 1999, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.